Hologic, Inc.

HOLX

US4364401012

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-11 pm EDT			5-day change	1st Jan Change
65.72 ^USD	-1.69%		+1.45%	-8.84%

Jul. 09	Tariff Drama, Minimal Market Reaction
Jul. 09	Citigroup Upgrades Hologic to Buy From Neutral, Adjusts Price Target to $80 From $60	MT

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

Published on 05/27/2025 at 14:47

By Josh Beckerman

Shares of Hologic advanced after the Financial Times reported the company received and rejected a nonbinding buyout offer from TPG and Blackstone.

The medical technology company's stock was up 14% to $62.08 on Tuesday. The stock is down 14% so far this year.

The FT article, which cited people familiar with the matter, said the firms offered to acquire Hologic for $70 to $72 per share. The story said it is possible that discussions might be revived.

Hologic and TPG didn't immediately respond to requests for comment and Blackstone declined to comment, the FT said.

The companies didn't immediately respond to requests for comment from Dow Jones Newswires.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

05-27-25 1446ET

Stocks mentioned in the article

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
BLACKSTONE INC.	162.00USD	-1.26%	+4.43%	125B
HOLOGIC, INC.	65.72USD	-1.69%	+1.45%	14.65B
TPG INC.	55.64USD	-0.63%	+2.90%	8.21B

Latest news about Hologic, Inc.

Tariff Drama, Minimal Market Reaction	Jul. 09
Citigroup Upgrades Hologic to Buy From Neutral, Adjusts Price Target to $80 From $60	Jul. 09	MT
Analyst recommendations: Illumina, Freeport-McMoran, XPO, T-Mobile US…	Jul. 09
Evercore ISI Adjusts Price Target on Hologic to $68 From $62, Maintains In Line Rating	Jul. 08	MT
Hologic, Inc.(NasdaqGS:HOLX) dropped from Russell 1000 Dynamic Index	Jun. 30	CI
BNP Paribas Exane Adjusts Price Target on Hologic to $73 From $71, Maintains Outperform Rating	Jun. 06	MT
Hologic, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-05-2025 11:05 AM	Jun. 05
Hologic, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-04-2025 04:00 PM	Jun. 04
Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation	Jun. 02	CI
Equity Markets Close Lower After Fed's May Minutes, Ahead of Nvidia Results	May. 28	MT
Equity Markets Lower After Fed Minutes Signal Caution	May. 28	MT
Global markets live: Nvidia, General Motors, Hologic, Chevron, Stellantis…	May. 28
Healthcare Stocks Higher -- Healthcare Roundup	May. 27	DJ
Dow, S&P 500 Log First Gains in 5 Days Amid EU Tariffs Delay	May. 27	MT
Equity Markets Close Higher Following EU Tariff Deadline Extension	May. 27	MT
US Equities Markets End Higher Tuesday as Trump Delays EU Tariffs	May. 27	MT
Sector Update: Health Care Stocks Advance Late Afternoon	May. 27	MT
Sector Update: Financial Stocks Advance Late Afternoon	May. 27	MT
Equity Markets Rise on EU Tariff Deadline Extension, US Consumer Sentiment Rebound	May. 27	MT
Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone	May. 27	DJ
EU Tariffs Delay, Consumer Confidence Report Boost US Equities Intraday	May. 27	MT
Top Midday Gainers	May. 27	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	May. 27	MT
Sector Update: Financial Stocks Advance Tuesday Afternoon	May. 27	MT
Hologic rejects over $16 billion take-private proposal from TPG and Blackstone, FT reports	May. 27	RE

Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostics (44.2%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin; - breast health (37.8%): digital mammography and breast biopsy solutions and systems; - gynecological surgery (15.9%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures; - bone health (2.1%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment. Net sales break down by source of revenue between sales of products (80.8%) and services (19.2%). Net sales are distributed geographically as follows: the United States (75%), Europe (13.2%), Asia-Pacific (6.5%) and others (5.3%).

Employees

7,063

Sector

Advanced Medical Equipment & Technology

Calendar

Jul. 30 - Q3 2025 Earnings Release

More about the company